Get the latest news on BioGaia stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BGLAF performance

Latest BioGaia Stock News | OTC:BGLAF | Benzinga

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

Comments

BioGaia Stock News

News

Latest BioGaia Stock News | OTC:BGLAF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga